ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
€ 54,50 0.00 (0.00%)
2023-08-21
PREÇO DA AÇÃO
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership2,517,424 shares
Ownership 11.30%
BlackRock, Inc. ownership in BSFA / ANI Pharmaceuticals, Inc.

2025-10-17 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,517,424 shares of ANI Pharmaceuticals, Inc. (DE:BSFA). This represents 11.3 percent ownership of the company. In their previous filing dated 2024-01-23 , BlackRock, Inc. had reported owning 2,524,660 shares, indicating a decrease of -0.29 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2025-10-17 2025-10-17 13G/A 2,524,660 2,517,424 -0.29 11.30 -8.87
2024-01-23 2024-01-23 13G/A 1,983,237 2,524,660 27.30 12.40 8.77
2023-01-26 2023-01-26 13G/A 1,983,237 1,983,237 0.00 11.40 0.00
2023-01-20 2023-01-20 13G/A 1,686,613 1,983,237 17.59 11.40 -3.39
2022-02-07 2022-02-07 13G/A 1,589,228 1,686,613 6.13 11.80 -8.53
2021-01-27 2021-01-27 13G/A 1,547,749 1,589,228 2.68 12.90 0.78
2021-01-27 2021-01-27 13G/A 1,589,228 1,589,228 0.00 12.90 0.00
2020-02-04 2020-02-04 13G/A 1,368,668 1,547,749 13.08 12.80 10.34
2019-01-24 2019-01-24 13G/A 1,274,351 1,368,668 7.40 11.60 6.42
2018-01-19 2018-01-19 13G/A 1,175,529 1,274,351 8.41 10.90 7.92
2017-08-10 2017-08-10 13G/A 1,070,224 1,175,529 9.84 10.10 9.78
2017-01-19 2017-01-19 13G/A 882,289 1,070,224 21.30 9.20 19.48
2016-01-25 2016-01-25 13G/A 882,289 7.70
2015-02-03 2015-02-03 13G 591,083 5.20
2012-06-08 2012-06-08 13G/A 5,655,478 4.68
2012-02-09 2012-02-09 13G 6,453,146 5.89

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2,747,492 85,780 3.22 211,282 0.56 0.0003
2026-02-12 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 2,661,712 112,820 4.43 210,116 -10.01 0.0036
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,548,892 -31,645 -1.23 233,479 38.66 0.0041
2025-08-12 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,580,537 -66,093 -2.50 168,380 -4.97 0.0032
2025-05-02 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2,646,630 -91,942 -3.36 177,192 17.04 0.0037
2025-02-07 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 2,738,572 48,860 1.82 151,388 -5.66 0.0031
2024-11-13 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,689,712 33,197 1.25 160,468 -5.14 0.0034
2024-08-13 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,656,515 125,172 4.94 169,167 -3.33 0.0038
2024-05-10 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2,531,343 6,450 0.26 174,992 25.69 0.0041
2024-02-13 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 2,524,893 23,923 0.96 139,223 -4.12 0.0035
2023-11-13 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,500,970 367,870 17.25 145,206 26.46 0.0042
2023-08-11 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,133,100 191,402 9.86 114,825 48.88 0.0032
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,941,698 -41,907 -2.11 77,124 -3.35 0.0023
2023-02-13 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,983,605 58,503 3.04 79,800 28.98 0.0025
2022-11-14 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,925,102 -53,391 -2.70 61,872 5.40 0.0021
2022-08-12 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,978,493 125,030 6.75 58,703 12.67 0.0019
2022-05-12 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,853,463 166,850 9.89 52,103 -32.96 0.0014
2022-02-10 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,686,613 174,984 11.58 77,721 56.66 0.0020
2021-11-09 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,511,629 -33,651 -2.18 49,611 -8.40 0.0014
2021-08-11 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,545,280 -106,005 -6.42 54,161 -9.24 0.0015
2021-05-07 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,651,285 62,057 3.90 59,677 29.31 0.0018
2021-02-05 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,589,228 74,231 4.90 46,151 7.99 0.0015
2020-11-06 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,514,997 -12,327 -0.81 42,737 -13.48 0.0016
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,527,324 70,475 4.84 49,394 -16.78 0.0020
2020-05-01 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,456,849 -90,900 -5.87 59,352 -37.82 0.0029
2020-02-13 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,547,749 9,199 0.60 95,450 -14.88 0.0037
2019-11-08 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,538,550 108,818 7.61 112,132 -4.59 0.0047
2019-08-22 2019-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 1,429,732 69,621 5.12 117,524 22.49 0.0050
2019-08-13 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,429,732 69,621 117,524
2019-05-09 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,360,111 -8,557 -0.63 95,943 55.71 0.0043
2019-02-08 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,368,668 -17,686 -1.28 61,618 -21.39 0.0031
2018-11-09 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,386,354 -4,820 -0.35 78,384 -15.65 0.0034
2018-08-09 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,391,174 94,786 7.31 92,931 23.12 0.0043
2018-05-09 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,296,388 22,037 1.73 75,478 -8.10 0.0036
2018-02-09 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,274,351 70 0.01 82,132 22.79 0.0039
2017-11-14 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,274,281 117,724 10.18 66,887 23.57 0.0034
2017-08-10 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,156,557 25,244 2.23 54,127 -3.36 0.0029
2017-05-12 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,131,313 1,130,697 183,554.71 56,010 151,278.38 0.0031
2017-02-10 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 616 -152 -19.79 37 -27.45 0.0001
2016-11-08 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 768 123 19.07 51 41.67 0.0001
2016-08-10 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 645 168 35.22 36 125.00 0.0001
2016-05-10 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 477 328 220.13 16 128.57 0.0000
2016-02-11 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 149 0 0.00 7 16.67 0.0000
2015-11-13 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 149 0 0.00 6 -33.33 0.0000
2015-08-07 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 149 -27 -15.34 9 -18.18 0.0000
2015-05-13 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 176 0 0.00 11 10.00 0.0000
2015-02-09 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 176 0 0.00 10 100.00 0.0000
2014-10-29 2014-09-30 13F ANI PHARMACEUTICALS COM 00182C103 176 0 0.00 5 -16.67 0.0000
2014-08-06 2014-06-30 13F ANI PHARMACEUTICALS COM 00182C103 176 176 6 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.